BMY vs CPF · P/E 17, rev $24.46B vs P/E 14, rev $26.2M
Bristol-Myers Squibb Company (BMY) versus Central Pacific Financial Corp (CPF) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Central Pacific Financial Corp (CPF) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CPF revenue for 2026-06-30 was $26.2M. Net income was $41.5M. CPF currently screens at market cap $789.3M and trailing P/E 13.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CPF currently screens at market cap $789.3M and trailing P/E 13.7.
Not investment advice. Open the BMY and CPF stock pages for the full models.
Not investment advice.